Z-0814-2022 Class III Terminated

Recalled by Cytocell Ltd. — Cambridge, N/A

FDA device recall Z-0814-2022 was initiated by Cytocell Ltd. on Feb 4, 2022 and is designated Class III. Reason for recall: May show unexpected locus specific signals in addition to those at 14q32. The recall status is terminated (terminated Nov 6, 2024). Affected quantity: 1 unit.

Recall details

Product Type
Devices
Report Date
Mar 30, 2022
Initiation Date
Feb 4, 2022
Termination Date
Nov 6, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1 unit

Product description

TCL1 Breakapart Probe, Fluorescence in situ hybridisation (FISH) is a technique allows the visualisation of DNA sequences upon chromosome Catalog Number: LPH046-A

Reason for recall

May show unexpected locus specific signals in addition to those at 14q32.

Distribution pattern

MN

Code information

Lot 074612

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0814-2022
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0814-2022. Report a data issue: hello@regdatalab.com.